Shannon Diversity: One Number for Your Gut's Ecological Health

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Measure your gut microbiome's diversity with a Shannon Diversity Test—low diversity is associated with conditions such as inflammatory bowel disease, obesity, metabolic syndrome, and immune/immune‑related dysfunction. Identifying low diversity early can help you and your clinician target diet, probiotic, and lifestyle changes to lower those risks.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Shannon diversity: One number for gut ecological health

The shannon diversity test summarizes “alpha diversity,” capturing two key features of your gut ecosystem: richness (how many different organisms) and evenness (how balanced they are). Results reflect your current ecosystem state rather than a fixed trait and can shift with diet, medications, illness, and travel.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why diversity earns its own index

Why it matters: your gut microbes help break down food, generate vitamins and short-chain fatty acids, train the immune system, and support the gut barrier that keeps unwanted compounds out of circulation. Diversity is a proxy for ecological resilience — a more varied, balanced community tends to buffer stress and maintain function. While microbiome science is evolving, consistent patterns show that stable diversity relates to favorable digestion, lower inflammatory tone, and metabolic flexibility.

The shannon diversity test translates complex sequencing data into a single, interpretable measure of your gut’s ecological health. Low diversity can accompany dysbiosis linked with digestive symptoms, post-antibiotic shifts, highly restrictive diets, or chronic stress. High diversity often aligns with a richer dietary fiber intake and more robust short-chain fatty acid production that nourishes colon cells and supports barrier integrity. Observational studies connect lower alpha diversity with several conditions (for example, inflammatory bowel disease and features of metabolic dysfunction), though patterns vary and associations do not prove causation. Testing is especially useful after major lifestyle changes, recurrent infections, or persistent GI issues when you and your clinician want to see if the ecosystem has stabilized.

Zooming out, the gut microbiome influences systemic health, from glucose handling and weight regulation to skin, mood, and immune balance. Repeating diversity measurements over time helps you see whether adjustments in diet quality, stress load, sleep, or movement are nudging your microbiome toward greater balance. The aim is not perfection — it is pattern recognition. Your diversity trend, interpreted alongside symptoms and other biomarkers, can guide thoughtful prevention and long-term wellness planning.

Reading a Shannon diversity result

Your report typically presents the Shannon diversity index as a numeric score and/or percentile relative to a reference population. It sits alongside taxonomic profiles (which organisms were detected) and sometimes functional pathways (what those microbes are capable of). In general, a “balanced” microbiome shows higher diversity with a healthy representation of beneficial genera such as Bifidobacterium and Faecalibacterium. Lower diversity, or dominance by a few species, can signal an imbalanced community. There is no single universal “normal” value; reference ranges vary by lab methods, sequencing depth, region of the world, age, and diet, so context is essential.

When diversity trends higher, it often tracks with efficient digestion, robust production of short-chain fatty acids like butyrate, and a calmer immune environment that supports a sturdy gut barrier. When it trends lower, it may point to reduced resilience, a tilt toward inflammation-associated species, or loss of beneficial organisms. These findings are directional, not diagnostic. They highlight functional patterns that may warrant exploration, from fiber quality and fermentable carbohydrate tolerance to the impact of recent antibiotics or infections.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What a Shannon diversity test can and can't tell you

Big picture: diversity is most powerful when integrated with your history and other biomarkers. Pair the shannon diversity test with stool inflammation (e.g., calprotectin), metabolic panels, or nutrient markers to connect microbial patterns with physiology. Remember key limitations: diversity reflects richness and evenness, not which specific microbes are driving symptoms; short-term factors (illness, colonoscopy prep, diarrhea, new supplements) can skew a single sample; and different assays and pipelines can yield slightly different scores. Viewed over time and in context, your diversity profile becomes a useful compass for digestion, energy, and long-term health strategy.

Frequently Asked Questions

References

  1. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012). Diversity, stability and resilience of the human gut microbiota. *Nature*, *489*(7415), 220-230. https://doi.org/10.1038/nature11550
  2. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, Jorgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, ... Pedersen O (2013). Richness of human gut microbiome correlates with metabolic markers. *Nature*, *500*(7464), 541-546. https://doi.org/10.1038/nature12506
  3. Human Microbiome Project Consortium. (2012). Structure, function and diversity of the healthy human microbiome. *Nature*, *486*(7402), 207-214. https://doi.org/10.1038/nature11234
  4. Sinha R, Abu-Ali G, Vogtmann E, Fodor AA, Ren B, Amir A, Schwager E, Crabtree J, Ma S, Microbiome Quality Control Project Consortium, Abnet CC, Knight R, White O, Huttenhower C (2017). Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. *Nature Biotechnology*, *35*(11), 1077-1086. https://doi.org/10.1038/nbt.3981
  5. Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R (2019). Microbiome 101: Studying, analyzing, and interpreting gut microbiome data for clinicians. *Clinical Gastroenterology and Hepatology*, *17*(2), 218-230. https://doi.org/10.1016/j.cgh.2018.09.017

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey